Sanuwave Health(SNWV)
$1.71+0.01 (+0.59%)
SNWV
Sanuwave Health financials statements
$1.71
At close:+0.01 (+0.59%)
Want to see SNWV full AI Analyst Report?
Sanuwave Health (SNWV) Ratios
55 Followers
Sanuwave Health Ratios
SNWV's free cash flow for Q3 2026 was $-1.06M. For the 2026 fiscal year, SNWV's free cash flow was decreased by $-206.00K and operating cash flow was $-851.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.38 | 0.43 | 0.15 | 0.11 | 0.08 |
| Quick Ratio | 1.05 | 0.34 | 0.11 | 0.10 | 0.06 |
| Cash Ratio | 0.67 | 0.24 | 0.03 | 0.02 | 0.01 |
| Solvency Ratio | 0.37 | -0.71 | -0.38 | -0.15 | -0.45 |
| Operating Cash Flow Ratio | 0.22 | 0.06 | -0.07 | -0.29 | -0.11 |
| Short-Term Operating Cash Flow Coverage | 0.69 | 0.10 | -0.15 | -0.45 | -0.24 |
| Net Current Asset Value | $ -11.10M | $ -24.44M | $ -55.81M | $ -54.26M | $ -53.18M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.62 | 0.85 | 1.36 | 1.96 | 1.52 |
| Debt-to-Equity Ratio | 14.19 | -2.00 | -0.71 | -0.95 | -0.73 |
| Debt-to-Capital Ratio | 0.93 | 2.00 | -2.39 | -19.16 | -2.68 |
| Long-Term Debt-to-Capital Ratio | 0.91 | 0.00 | 0.00 | 0.00 | -0.02 |
| Financial Leverage Ratio | 23.07 | -2.37 | -0.52 | -0.48 | -0.48 |
| Debt Service Coverage Ratio | 1.63 | -0.43 | -0.20 | 0.09 | -0.55 |
| Interest Coverage Ratio | 0.79 | 0.40 | -0.03 | -0.63 | -1.99 |
| Debt to Market Cap | 0.09 | 0.25 | 2.91 | 3.08 | 0.32 |
| Interest Debt Per Share | 3.41 | 8.77 | 21.77 | 36.24 | 25.67 |
| Net Debt to EBITDA | 0.57 | -0.92 | -3.13 | 7.89 | -1.47 |
| Profitability Margins | |||||
| Gross Profit Margin | 77.11% | 75.23% | 70.41% | 74.13% | 61.68% |
| EBIT Margin | 41.19% | -54.26% | -49.91% | 22.94% | -154.77% |
| EBITDA Margin | 44.10% | -50.75% | -44.87% | 28.63% | -145.27% |
| Operating Profit Margin | 11.23% | 16.60% | -2.65% | -53.47% | -108.70% |
| Pretax Profit Margin | 27.01% | -96.05% | -126.50% | -61.47% | -209.31% |
| Net Profit Margin | 26.82% | -96.13% | -126.52% | -61.48% | -209.52% |
| Continuous Operations Profit Margin | 26.82% | -96.13% | -126.52% | -61.48% | -209.52% |
| Net Income Per EBT | 99.28% | 100.09% | 100.02% | 100.02% | 100.10% |
| EBT Per EBIT | 240.63% | -578.64% | 4778.33% | 114.96% | 192.55% |
| Return on Assets (ROA) | 31.63% | -104.16% | -115.13% | -51.79% | -146.40% |
| Return on Equity (ROE) | 729.65% | 246.69% | 59.77% | 25.10% | 69.97% |
| Return on Capital Employed (ROCE) | 25.36% | -44.31% | 1.28% | 22.19% | 37.57% |
| Return on Invested Capital (ROIC) | 19.41% | 41.42% | 4.36% | 496.23% | 137.94% |
| Return on Tangible Assets | 43.66% | -164.00% | -240.69% | -137.68% | -494.00% |
| Earnings Yield | 4.62% | -30.56% | -250.32% | -82.16% | -30.93% |
| Efficiency Ratios | |||||
| Receivables Turnover | 8.12 | 9.80 | 6.16 | 4.16 | 5.39 |
| Payables Turnover | 3.13 | 2.17 | 1.06 | 0.98 | 0.65 |
| Inventory Turnover | 1.70 | 1.95 | 2.05 | 4.99 | 4.79 |
| Fixed Asset Turnover | 18.65 | 44.58 | 21.75 | 19.56 | 12.86 |
| Asset Turnover | 1.18 | 1.08 | 0.91 | 0.84 | 0.70 |
| Working Capital Turnover Ratio | -5.13 | -0.83 | -0.38 | -0.32 | -0.32 |
| Cash Conversion Cycle | 143.22 | 56.24 | -107.26 | -209.83 | -415.69 |
| Days of Sales Outstanding | 44.93 | 37.23 | 59.30 | 87.84 | 67.75 |
| Days of Inventory Outstanding | 214.83 | 187.33 | 178.48 | 73.15 | 76.13 |
| Days of Payables Outstanding | 116.54 | 168.32 | 345.04 | 370.82 | 559.58 |
| Operating Cycle | 259.76 | 224.56 | 237.78 | 160.99 | 143.89 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.45 | 0.55 | -2.14 | -11.72 | -4.64 |
| Free Cash Flow Per Share | 0.23 | 0.44 | -2.14 | -11.02 | -5.02 |
| Dividend Paid and CapEx Coverage Ratio | 2.00 | 5.01 | 0.00 | -16.80 | -12.12 |
| Capital Expenditure Coverage Ratio | 2.00 | 5.01 | 0.00 | -16.80 | -12.12 |
| Operating Cash Flow Coverage Ratio | 0.17 | 0.10 | -0.15 | -0.44 | -0.23 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.08 | -0.22 | -1.03 | -0.49 |
| Free Cash Flow Yield | 0.76% | 1.91% | -44.02% | -128.89% | -7.87% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.62 | -3.27 | -0.40 | -1.22 | -3.23 |
| Price-to-Sales (P/S) Ratio | 5.80 | 3.15 | 0.51 | 0.75 | 6.77 |
| Price-to-Book (P/B) Ratio | 157.84 | -8.07 | -0.24 | -0.31 | -2.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 132.13 | 52.24 | -2.27 | -0.78 | -12.70 |
| Price-to-Operating Cash Flow Ratio | 65.93 | 41.81 | -2.27 | -0.73 | -13.75 |
| Price-to-Earnings Growth (PEG) Ratio | -0.18 | 0.08 | -0.01 | 0.02 | 0.09 |
| Enterprise Value Multiple | 13.72 | -7.12 | -4.26 | 10.51 | -6.13 |
| Enterprise Value | 266.55M | 117.91M | 38.97M | 50.35M | 115.89M |
| EV to EBITDA | 13.72 | -7.12 | -4.26 | 10.51 | -6.13 |
| EV to Sales | 6.05 | 3.61 | 1.91 | 3.01 | 8.91 |
| EV to Free Cash Flow | 137.82 | 60.00 | -8.59 | -3.12 | -16.70 |
| EV to Operating Cash Flow | 68.77 | 48.03 | -8.59 | -2.93 | -18.08 |
| Tangible Book Value Per Share | -1.01 | -5.31 | -25.92 | -36.45 | -37.66 |
| Shareholders’ Equity Per Share | 0.19 | -2.85 | -20.40 | -27.99 | -28.18 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 |
| Revenue Per Share | 5.14 | 7.31 | 9.64 | 11.43 | 9.41 |
| Net Income Per Share | 1.38 | -7.03 | -12.19 | -7.02 | -19.72 |
| Tax Burden | 0.99 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.66 | 1.77 | 2.53 | -2.68 | 1.35 |
| Research & Development to Revenue | 0.03 | 0.02 | 0.03 | 0.03 | 0.08 |
| SG&A to Revenue | 0.61 | 0.54 | 0.43 | 0.75 | 0.90 |
| Stock-Based Compensation to Revenue | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.33 | -0.08 | 0.18 | 1.67 | 0.24 |
Currency in USD

